BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2683974)

  • 1. [Antagonist and agonist effects of the antiprogesterone RU 486].
    Schaison G
    Ann Endocrinol (Paris); 1989; 50(3):200-7. PubMed ID: 2683974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.
    Groyer A; Schweizer-Groyer G; Cadepond F; Mariller M; Baulieu EE
    Nature; 1987 Aug 13-19; 328(6131):624-6. PubMed ID: 3614365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiglucocorticoid action of RU 486].
    Bertagna X
    Ann Endocrinol (Paris); 1989; 50(3):208-17. PubMed ID: 2554782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
    Fukuoka H; Jimbo T
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary gland explant cultures. Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue.
    Jahn GA; Houdebine LM; Djiane J
    J Steroid Biochem; 1987 Oct; 28(4):371-7. PubMed ID: 3669658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form.
    el-Ashry D; Oñate SA; Nordeen SK; Edwards DP
    Mol Endocrinol; 1989 Oct; 3(10):1545-58. PubMed ID: 2608048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
    Renoir JM; Radanyi C; Baulieu EE
    Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU486 (an anti-steroid hormone) receptor structure and heat shock protein mol. wt 90,000 (hsp 90).
    Baulieu EE
    Hum Reprod; 1988 May; 3(4):541-7. PubMed ID: 3292573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation.
    Allan GF; Leng X; Tsai SY; Weigel NL; Edwards DP; Tsai MJ; O'Malley BW
    J Biol Chem; 1992 Sep; 267(27):19513-20. PubMed ID: 1326555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
    Baulieu EE
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of antihormone action.
    Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo.
    Truss M; Bartsch J; Beato M
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11333-7. PubMed ID: 7972059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihormone-steroid hormonal activity, heat-shock protein hsp 90 and receptors.
    Baulieu EE
    Horm Res; 1987; 28(2-4):181-95. PubMed ID: 3454344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormone antagonists at the receptor level: a role for the heat-shock protein MW 90,000 (hsp 90).
    Baulieu EE
    J Cell Biochem; 1987 Oct; 35(2):161-74. PubMed ID: 3323207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11 beta-substituted 13 beta-ethyl gonane derivatives exhibit reversal of antiprogestational activity.
    Rao PN; Cessac JW; Blye RP; Kim HK
    Steroids; 1998 Jan; 63(1):50-7. PubMed ID: 9437795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. History and perspectives of antiprogestins from the chemist's point of view.
    Teutsch G; Philibert D
    Hum Reprod; 1994 Jun; 9 Suppl 1():12-31. PubMed ID: 7962457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New analogues of mifepristone with more dissociated antiprogesterone activities.
    Philibert D; Hardy M; Gaillard-Moguilewsky M; Nique F; Tournemine C; Nédélec L
    J Steroid Biochem; 1989; 34(1-6):413-7. PubMed ID: 2560520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.